Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
PLD1 inhibitor is an inhibitor of phospholipase D1 (PLD1).1 It inhibits PLD activity in PLD1-overexpressing A549 cells (IC50 = 1.97 µM). PLD1 inhibitor reduces the viability of A549 lung cancer and HCT116 colorectal cancer cells (IC50s = 18 and 29 µM, respectively). It also inhibits the proliferation, migration, and invasion of A549 cells and induces apoptosis in the same cells. PLD1 inhibitor (10 mg/kg every other day) reduces tumor growth, induces intratumoral apoptosis, and decreases Ras, CD47, CD24, and programmed cell death 1 ligand 1 (PD-L1) levels in a murine Lewis lung carcinoma model.
WARNING This product is not for human or veterinary use.
1. Development and evaluation of indole-